Kapiva, a direct-to-consumer Ayurvedic products startup, is close to securing Rs 330 crore in an internal funding round.

Kapiva, a direct-to-consumer (D2C) Ayurvedic brand, is preparing to raise approximately Rs 300-330 crore (around $40 million) in an internal funding round aimed at expanding its operations and boosting its market presence, according to sources cited by Money control OrbiMed, an existing investor, is expected to lead the round, with participation from other investors like Fireside Ventures, Vertex Ventures, and 3one4 Capital. 

Founded in 2016, Kapiva offers a range of Ayurvedic nutrition products such as juices, teas, oils, and shakes that address issues like hair fall, weight loss, diabetes, and digestion. Investors are showing increased interest in Kapiva as consumers are willing to spend on premium health and wellness products. Overall, there has been a surge in investor backing for consumer-focused companies.